Marine Drugs | |
Kalkitoxin Inhibits Angiogenesis, Disrupts Cellular Hypoxic Signaling, and Blocks Mitochondrial Electron Transport in Tumor Cells | |
J. Brian Morgan1  Yang Liu1  Veena Coothankandaswamy1  Fakhri Mahdi1  Mika B. Jekabsons4  William H. Gerwick5  Frederick A. Valeriote3  Yu-Dong Zhou1  Dale G. Nagle1  Sergey A. Dyshlovoy2  | |
[1] Department of BioMolecular Sciences and Research Institute of Pharmaceutical Sciences, School of Pharmacy, University of Mississippi, University, MS 38677, USA; E-Mails:Department of BioMolecular Sciences and Research Institute of Pharmaceutical Sciences, School of Pharmacy, University of Mississippi, University, MS 38677, USA;;Department of Internal Medicine, Division of Hematology and Oncology, Henry Ford Hospital, Detroit, MI 48202, USA; E-Mail:;Department of Biology, University of Mississippi, University, MS 38677, USA; E-Mail:;Center for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography and Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA 920933, USA; E-Mail: | |
关键词:
kalkitoxin;
breast cancer;
|
|
DOI : 10.3390/md13031552 | |
来源: mdpi | |
【 摘 要 】
The biologically active lipopeptide kalkitoxin was previously isolated from the marine cyanobacterium
【 授权许可】
CC BY
© 2015 by the authors; licensee MDPI, Basel, Switzerland.
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO202003190014900ZK.pdf | 989KB | download |